The global Personalized Genomics market is anticipated to grow at a growth rate of 18.3% to reach USD 34,790.8 million by 2030.

Personalized genomics is a specialized branch of genomics and genetics focused on tailoring medical strategies, lifestyle recommendations, and interventions based on an individual's unique genetic makeup. It involves the analysis of an individual's genetic data to offer personalized insights into disease susceptibility, overall health, and likely responses to specific treatments.

The driving forces behind the rapid growth of personalized genomics include a rising emphasis on preventive healthcare, the decreasing costs associated with genomic sequencing technologies, and an increasing demand for customized therapeutic approaches. This field holds immense promise in revolutionizing healthcare by enabling more precise and effective treatments tailored to each person's genetic profile, ultimately improving health outcomes and patient well-being.

Request Sample Copy of Report of Global Personalized Genomics Market

The dramatic reduction in sequencing costs over the last ten years has been a pivotal driver, significantly enhancing the affordability and accessibility of genomic testing. The expense of sequencing an entire human genome, which stood at over $10 million in 2007, has plummeted to approximately $600 today.

This cost transformation has democratized genomics, opening doors to widespread adoption in medical research, clinical diagnostics, and personalized medicine. The affordability of genomic testing fuels innovation and fosters a broader understanding of genetic factors in health and disease. Consequently, it propels the growth of the genomics industry and empowers individuals to make informed healthcare decisions based on their genetic information.

KEY INSIGHTS OF THIS REPORT:

• Concerning the type of tests conducted, Oncology emerged as a major contributor to revenue share. This highlights the growing importance of genomic testing in the field of cancer diagnostics and treatment. Genomic insights play a pivotal role in tailoring precise and effective therapies, contributing significantly to advancements in oncology care and research.
• In the upcoming forecast period, North America is projected to emerge as the dominant market in the field of Personalized Genomics, holding a substantial market share of over 40% in the year 2023.
• This growth in North America can be attributed to several key factors. Firstly, the region has a robust and well-established healthcare infrastructure that readily embraces advanced genomic technologies. Secondly, there is a growing awareness and demand for personalized healthcare solutions among both healthcare providers and patients.
• In November 2021, Ancestry introduced AncestryHealth+, offering consumers access to genetic counselors for interpreting health reports and incorporating family health history features.
• This development has had a significant impact on the growth of the personalized genomics market. By providing users with access to genetic counseling services, AncestryHealth+ enhances the value of genetic testing, making it more comprehensive and user-friendly.

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERSONALIZED GENOMICS MARKET SEGMENTATION

GLOBAL PERSONALIZED GENOMICS MARKET KEY PLAYERS

• Qiagen
• Gene by Gene
• Thermo Fisher Scientific
• 23andMe
• Color Genomics
• Illumina
• Ancestry
• Mapmygenome
• Xcode
• Helix
• MyHeritage
• Pathway Genomics
• Quest Diagnostics
• Futura Genetics
• Laboratory Corporation of America
• Myriad Genetics
• Veritas Genetics
• Nebula Genomics
• Positive Biosciences
• Genomic Health
• Others

GLOBAL PERSONALIZED GENOMICS MARKET, BY TEST TYPE

• Neurology or Psychiatry
• Oncology
• Cardiovascular
• Infectious disease
• Others

GLOBAL PERSONALIZED GENOMICS MARKET, BY TECHNOLOGY

• Sequencing-based Tests
• PCR-based Tests
• Microarray-based Tests
• Others

GLOBAL PERSONALIZED GENOMICS MARKET, BY APPLICATION

• Lifestyle
• Wellness
• Diagnostics
• Reproductive Health
• Precision Medicine
• Sports Nutrition & Health
• Others

GLOBAL PERSONALIZED GENOMICS MARKET, BY END USER

• Diagnostic Laboratories
• Hospitals & Clinics
• Research Centers
• Pharmaceutical & Biotechnology Companies
• Others

GLOBAL PERSONALIZED GENOMICS MARKET, BY REGION

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
• Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
• The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA